Tower Research Capital (TRC)’s Ovid Therapeutics OVID Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$17K Buy
51,520
+27,674
+116% +$9.13K ﹤0.01% 3765
2025
Q1
$7.44K Buy
23,846
+14,006
+142% +$4.37K ﹤0.01% 3952
2024
Q4
$9.19K Buy
9,840
+1,539
+19% +$1.44K ﹤0.01% 3927
2024
Q3
$9.8K Sell
8,301
-5,876
-41% -$6.93K ﹤0.01% 3832
2024
Q2
$10.9K Sell
14,177
-9,958
-41% -$7.66K ﹤0.01% 4117
2024
Q1
$73.6K Buy
24,135
+19,752
+451% +$60.2K ﹤0.01% 2016
2023
Q4
$14.1K Buy
4,383
+346
+9% +$1.11K ﹤0.01% 3905
2023
Q3
$15.5K Buy
4,037
+549
+16% +$2.11K ﹤0.01% 3611
2023
Q2
$11.4K Sell
3,488
-1,822
-34% -$5.98K ﹤0.01% 3951
2023
Q1
$14K Sell
5,310
-15,006
-74% -$39.6K ﹤0.01% 3902
2022
Q4
$38K Sell
20,316
-11,749
-37% -$22K ﹤0.01% 2546
2022
Q3
$59K Buy
32,065
+14,062
+78% +$25.9K ﹤0.01% 3014
2022
Q2
$39K Buy
18,003
+14,010
+351% +$30.4K ﹤0.01% 3125
2022
Q1
$13K Buy
3,993
+212
+6% +$690 ﹤0.01% 3992
2021
Q4
$12K Sell
3,781
-3,710
-50% -$11.8K ﹤0.01% 4310
2021
Q3
$25K Buy
7,491
+3,967
+113% +$13.2K ﹤0.01% 3529
2021
Q2
$14K Sell
3,524
-5,914
-63% -$23.5K ﹤0.01% 4184
2021
Q1
$38K Sell
9,438
-33,119
-78% -$133K ﹤0.01% 3357
2020
Q4
$98K Buy
42,557
+2,011
+5% +$4.63K ﹤0.01% 2373
2020
Q3
$233K Buy
40,546
+38,421
+1,808% +$221K ﹤0.01% 2436
2020
Q2
$16K Sell
2,125
-8,842
-81% -$66.6K ﹤0.01% 3791
2020
Q1
$33K Sell
10,967
-8,096
-42% -$24.4K ﹤0.01% 1480
2019
Q4
$79K Buy
+19,063
New +$79K 0.01% 1075
2019
Q3
Sell
-3,264
Closed -$6K 4401
2019
Q2
$6K Sell
3,264
-6,269
-66% -$11.5K ﹤0.01% 2856
2019
Q1
$17K Buy
9,533
+240
+3% +$428 ﹤0.01% 2365
2018
Q4
$23K Buy
9,293
+2,920
+46% +$7.23K ﹤0.01% 1826
2018
Q3
$36K Buy
+6,373
New +$36K ﹤0.01% 1967
2018
Q2
Sell
-724
Closed -$5K 3946
2018
Q1
$5K Buy
+724
New +$5K ﹤0.01% 2715
2017
Q4
Sell
-246
Closed -$2K 3924
2017
Q3
$2K Buy
+246
New +$2K ﹤0.01% 3582
2017
Q2
Hold
0
3307